Masimo Price to Free Cash Flow Ratio 2010-2023 | MASI
Historical price to free cash flow ratio values for Masimo (MASI) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Masimo Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-04-24 | 135.92 | 146.77 | |
| 2023-12-31 | 117.21 | $0.93 | 126.56 |
| 2023-09-30 | 87.68 | $-0.72 | 0.00 |
| 2023-06-30 | 164.55 | $-0.28 | 0.00 |
| 2023-03-31 | 184.54 | $-0.62 | 0.00 |
| 2022-12-31 | 147.95 | $-0.42 | 0.00 |
| 2022-09-30 | 141.16 | $1.61 | 87.87 |
| 2022-06-30 | 130.67 | $2.83 | 46.22 |
| 2022-03-31 | 145.54 | $3.32 | 43.82 |
| 2021-12-31 | 292.78 | $4.14 | 70.65 |
| 2021-09-30 | 270.71 | $3.44 | 78.64 |
| 2021-06-30 | 242.45 | $2.69 | 90.29 |
| 2021-03-31 | 229.66 | $3.17 | 72.53 |
| 2020-12-31 | 268.38 | $2.39 | 112.31 |
| 2020-09-30 | 236.06 | $2.50 | 94.28 |
| 2020-06-30 | 227.99 | $3.00 | 75.98 |
| 2020-03-31 | 177.12 | $2.78 | 63.78 |
| 2019-12-31 | 158.06 | $3.74 | 42.30 |
| 2019-09-30 | 148.79 | $3.51 | 42.41 |
| 2019-03-31 | 138.28 | $3.36 | 41.10 |
| 2018-12-31 | 107.37 | $3.97 | 27.05 |
| 2018-09-30 | 124.54 | $3.68 | 33.84 |
| 2018-06-30 | 97.65 | $2.77 | 35.25 |
| 2018-03-31 | 87.95 | $1.28 | 68.75 |
| 2017-12-31 | 84.80 | $0.22 | 382.84 |
| 2017-09-30 | 86.56 | $5.58 | 15.52 |
| 2017-06-30 | 91.18 | $6.21 | 14.67 |
| 2017-03-31 | 93.26 | $7.42 | 12.57 |
| 2016-12-31 | 67.40 | $7.51 | 8.98 |
| 2016-09-30 | 59.49 | $2.35 | 25.33 |
| 2016-06-30 | 52.52 | $2.04 | 25.71 |
| 2016-03-31 | 41.84 | $1.47 | 28.51 |
| 2015-12-31 | 41.51 | $1.24 | 33.37 |
| 2015-09-30 | 38.56 | $0.65 | 59.00 |
| 2015-06-30 | 38.74 | $0.85 | 45.42 |
| 2015-03-31 | 32.98 | $0.04 | 818.36 |
| 2014-12-31 | 26.34 | $0.37 | 71.23 |
| 2014-09-30 | 21.28 | $0.07 | 284.87 |
| 2014-06-30 | 23.60 | $-0.11 | 0.00 |
| 2014-03-31 | 27.31 | $0.22 | 122.58 |
| 2013-12-31 | 29.23 | $-0.31 | 0.00 |
| 2013-09-30 | 26.64 | $-0.13 | 0.00 |
| 2013-06-30 | 21.20 | $0.04 | 478.56 |
| 2019-06-30 | 148.82 | $0.58 | 258.37 |
| 2012-12-31 | 21.01 | $1.11 | 18.98 |
| 2012-09-30 | 23.07 | $1.66 | 13.91 |
| 2012-06-30 | 21.35 | $1.67 | 12.80 |
| 2012-03-31 | 22.31 | $1.87 | 11.93 |
| 2011-12-31 | 17.83 | $1.79 | 9.96 |
| 2013-03-31 | 19.62 | $1.23 | 15.97 |
| 2011-09-30 | 20.64 | $0.89 | 23.28 |
| 2011-06-30 | 28.32 | $0.82 | 34.46 |
| 2011-03-31 | 31.58 | $0.54 | 58.94 |
| 2010-12-31 | 27.74 | $0.85 | 32.67 |
| 2010-09-30 | 25.46 | $1.07 | 23.87 |
| 2010-06-30 | 22.20 | $1.13 | 19.62 |
| 2010-03-31 | 24.75 | $1.20 | 20.63 |
| 2009-12-31 | 26.39 | $0.72 | 36.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.246B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.329B | 26.67 |
| Intuitive Surgical (ISRG) | United States | $133.752B | 80.57 |
| DexCom (DXCM) | United States | $53.067B | 88.74 |
| Edwards Lifesciences (EW) | United States | $52.819B | 34.96 |
| IQVIA Holdings (IQV) | United States | $43.310B | 25.69 |
| IDEXX Laboratories (IDXX) | United States | $41.012B | 49.04 |
| Alcon (ALC) | Switzerland | $39.823B | 29.37 |
| STERIS (STE) | Ireland | $20.355B | 24.09 |
| Waters (WAT) | United States | $18.582B | 26.66 |
| Hologic (HOLX) | United States | $18.119B | 20.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.651B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.605B | 15.56 |
| ShockWave Medical (SWAV) | United States | $12.286B | 84.89 |
| Sysmex ADR (SSMXY) | Japan | $10.120B | 31.74 |
| Teleflex (TFX) | United States | $9.944B | 15.61 |
| Penumbra (PEN) | United States | $7.961B | 98.42 |
| Globus Medical (GMED) | United States | $6.941B | 22.00 |
| Glaukos (GKOS) | United States | $5.074B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.950B | 25.25 |
| LivaNova (LIVN) | United Kingdom | $2.969B | 19.58 |
| TransMedics (TMDX) | United States | $2.964B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.763B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.704B | 18.55 |
| Nihon Kohden (NHNKY) | Japan | $2.379B | 20.12 |
| Integra LifeSciences Holdings (IART) | United States | $2.309B | 9.48 |
| Tandem Diabetes Care (TNDM) | United States | $2.258B | 0.00 |
| Inari Medical (NARI) | United States | $2.151B | 371.10 |
| RxSight (RXST) | United States | $2.031B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.784B | 0.00 |
| Veracyte (VCYT) | United States | $1.489B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.867B | 16.03 |
| Artivion (AORT) | United States | $0.856B | 98.95 |
| Paragon 28 (FNA) | United States | $0.833B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.729B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.575B | 19.53 |
| IRadimed (IRMD) | United States | $0.531B | 30.81 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Nevro (NVRO) | United States | $0.469B | 0.00 |
| NeuroPace (NPCE) | United States | $0.402B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.379B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.346B | 11.66 |
| CVRx (CVRX) | United States | $0.309B | 0.00 |
| AxoGen (AXGN) | United States | $0.305B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.279B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| Accuray (ARAY) | United States | $0.220B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.26 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.116B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.33 |
| Vasomedical (VASO) | United States | $0.054B | 9.73 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.021B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |